Study Summary
This study aims to explore the safety, tolerability and preliminary efficacy of Anti-Mesothelin CAR-T cells in subjects with Mesothelin-positive advanced malignant solid tumors.
Want to learn more about this trial?
Request More InfoInterventions
Anti-mesothelin CAR-T cellsBIOLOGICAL
Anti-mesothelin CAR-T cells are autologous genetically modified T cells. Cells will be infused intravenously.
Study Locations
No locations listed.